Home Newsletters Neural Cell News Identification of Pimavanserin Tartrate as a Potent Ca2+-Calcineurin-NFAT Pathway Inhibitor for Glioblastoma...

Identification of Pimavanserin Tartrate as a Potent Ca2+-Calcineurin-NFAT Pathway Inhibitor for Glioblastoma Therapy

0
Researchers carried out research to discover a novel alternative drug targeting the oncogenic NFAT signaling pathway for Glioblastoma multiforme therapy.
[Acta Pharmacologica Sinica]

Sorry, but the selected Zotpress account can't be found.

Abstract
Exit mobile version